Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
The Most recent Microsoft Surface Genius PC: Ideal for Very good quality Planning and Gaming Needs - 2Congress is running out of time to extend ACA subsidies as the GOP moves on to an alternative plan. Here's where things stand.
- 3Empathy and reasoning aren’t rivals – new research shows they work together to drive people to help more
- 4What to know about cheese voluntarily recalled in 20 states
- 5IDF destroys Hamas shaft in northern Gaza with loaded 'ready to fire' rocket aimed at Sderot
- Step by step instructions to Boost the Eco-friendliness of Your Smash 1500.
- I'm an 83-year-old yoga instructor. I'm not your typical grandma — I still work to feel fulfilled and supplement my Social Security.
- Instructions to Help a Friend or family member Determined to have Cellular breakdown in the lungs
- Pilot captures jaw-dropping northern lights show from 36,000 feet (photos)
- Baby takes 1st steps after receiving groundbreaking gene-edited therapy
- Geminid shooting stars: One of 2025's most exciting meteor showers begins tonight
- Bomb blast in packed Nigerian mosque kills five
- Exploring the Market: Unsold Rams May Be Less expensive Than You Naturally suspect
- New Gaza militia declares war on Hamas: 'Your dirty shoes are more honorable'
